Publications

• Collado S, Coll E, Deulofeu R, Guerrero L, Pons M, Cruzado JM, de la Torre B, Vera M, Azqueta M, Nicolau C, Cases A. [Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors]. Nefrologia 2010; 30(3): 342-8

  IF: 0, Quartile: 4

  View abstract

• Fort J, Cuevas X, García F, Pérez-García R, Lladós F, Lozano J, Martín-Malo A. Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study. Nephrol. Dial. Transplant. 2010 Aug; 25(8): 2702-10

  IF: 3.356, Quartile: 1

  View abstract

• Sanchis J, Núñez J, Bodí V, Núñez E, Garcia-Alvarez A, Bonanad C, Regueiro A, Bosch X, Heras M, Sala J, Bielsa O, Llàcer A. Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome. Mayo Clin. Proc. 2011 Apr; 86(4): 291-6

  IF: 4.973, Quartile: 1, Decile: 1

  View abstract

• Arango O, Lorente JA, Nohales G, Rijo E, Bielsa O. Superficial dorsal penile vein thrombosis: a little-known complication of subinguinal varicocelectomy. BJU Int. 2011 Jan; 107(1): 95-8

  IF: 2.865, Quartile: 1

  View abstract

• Bosch D, Masiá R, Sala J, Vila J, Ramos R, Elosua R, Subirana I, Heras M, Sanchis J, Grau M, Brugada R, Marrugat J. Effect of opening a new catheterization laboratory on 30-day and 2-year survival rates in myocardial infarction patients. Rev Esp Cardiol 2011 Feb; 64(2): 96-104

  IF: 2.746, Quartile: 2

  View abstract

• Oliveras A, de la Sierra A, Martínez-Estrada OM, Larrousse M, Vázquez S, Soler MJ, Zuasti M, Vila JS, Reina M, Roca-Cusachs A, Lloveras J. Putative endothelial progenitor cells are associated with flow-mediated dilation in refractory hypertensives. Blood Press. 2008; 17(5): 298-305

  IF: 1.625, Quartile: 3

  View abstract

• Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK, Oliveras A. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N. Engl. J. Med. 2008 Jun; 358(23): 2433-46

  IF: 50.017, Quartile: 1, Decile: 1

  View abstract

• Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Le Heuzey JY, Crijns HJ, Olsson SB, Olsson S, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann L, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Guyton RA, Tarkington LG, Yancy CW. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011 Jan; 123(1): 104-23

  IF: 14.816, Quartile: 1, Decile: 1

  View abstract

• Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Le Heuzey JY, Crijns HJ, Olsson SB, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Guyton RA, Tarkington LG, Yancy CW. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2011 Jan; 57(2): 223-42

  IF: 14.293, Quartile: 1, Decile: 1

  View abstract

• Tamargo J, Tamarg J, Amorós I, Barana A, Caballero R, Delpón E. New investigational drugs for the management of acute heart failure syndromes. Curr. Med. Chem. 2010; 17(4): 363-90

  IF: 4.708, Quartile: 1

  View abstract

• Amorós I, Jiménez-Jáimez J, Tercedor L, Barana A, Gómez R, de la Fuente MG, Dolz-Gaitón P, Alvarez M, Martínez-Espín E, Lorente JA, Melgares R, Tamargo J, Delpón E, Caballero R. Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome. Heart Rhythm 2011 Mar; 8(3): 463-70

  IF: 4.559, Quartile: 1

  View abstract

• Farré AJ, Tamargo J, Mateos-Cáceres PJ, Azcona L, Macaya C. Old and new molecular mechanisms associated with platelet resistance to antithrombotics. Pharm. Res. 2010 Nov; 27(11): 2365-73

  IF: 3.933, Quartile: 1

  View abstract

• Prystowsky EN, Camm J, Lip GY, Allessie M, Bergmann JF, Breithardt G, Brugada J, Crijns H, Ellinor PT, Mark D, Naccarelli G, Packer D, Tamargo J. The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. J. Cardiovasc. Electrophysiol. 2010 Aug; 21(8): 946-58

  IF: 3.703, Quartile: 1

  View abstract

• Mont L, Sambola A, Brugada J, Vacca M, Marrugat J, Elosua R, Paré C, Azqueta M, Sanz G. Long-lasting sport practice and lone atrial fibrillation. Eur. Heart J. 2002 Mar; 23(6): 477-82

  IF: 6.131, Quartile: 1, Decile: 1

  View abstract

• Ferreira-González I, Marsal JR, Mitjavila F, Parada A, Ribera A, Cascant P, Soriano N, Sánchez PL, Arós F, Heras M, Bueno H, Marrugat J, Cuñat J, Civeira E, Permanyer-Miralda G. Patient registries of acute coronary syndrome: assessing or biasing the clinical real world data? Circ Cardiovasc Qual Outcomes 2009 Nov; 2(6): 540-7

  IF: 0

  View abstract